Recruitment and Activation of Naive T Cells in the Islets by Lymphotoxin β Receptor-Dependent Tertiary Lymphoid Structure

Immunity

Volumn 25, Issue 3, 2006, Pages 499-509

  Lee, Youjin ^a   Chin, Robert K ^a   Christiansen, Peter ^a   Sun, Yonglian ^a   Tumanov, Alexei V ^a   Wang, Jing ^a   Chervonsky, Alexander V ^a   Fu, Yang Xin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

CELLIMMUNO; HUMDISEASE

Indexed keywords

CYTOKINE; LYMPHOTOXIN BETA RECEPTOR; TNFSFF14 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; ORGANOGENESIS; PANCREAS ISLET CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE ACTIVATION; TERTIARY LYMPHOID ORGAN;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; FEMALE; G0 PHASE; HUMANS; IMMUNOGLOBULINS; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; LYMPHOTOXIN BETA RECEPTOR; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PREDIABETIC STATE; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748622563     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.06.016     Document Type: Article

References (45)

1. Aloisi F. Lymphoid neogenesis in chronic infammatory diseases. Nat. Rev. Immunol. 6 (2006) 205-217
2. Anders R.A., Subudhi S.K., Wang J., Pfeffer K., and Fu Y.X. Contribution of the lymphotoxin beta receptor to liver regeneration. J. Immunol. 175 (2005) 1295-1300
3. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15 (1994) 516-542
4. Bach J.F., and Mathis D. The NOD mouse. Res. Immunol. 148 (1997) 285-286
5. Browning J.L., Sizing I.D., Lawton P., Bourdon P.R., Rennert P.D., Majeau G.R., Ambrose C.M., Hession C., Miatkowski K., Griffiths D.A., et al. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J. Immunol. 159 (1997) 3288-3298
6. Browning J.L., Allaire N., Ngam-Ek A., Notidis E., Hunt J., Perrin S., and Fava R.A. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 23 (2005) 539-550
7. Butcher E.C., and Picker L.J. Lymphocyte homing and homeostasis. Science 272 (1996) 60-66
8. Chen S.C., Vassileva G., Kinsley D., Holzmann S., Manfra D., Wiekowski M.T., Romani N., and Lira S.A. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168 (2002) 1001-1008
9. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 286 (1999) 2098-2102
10. Delovitch T.L., and Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7 (1997) 727-738
11. Drayton D.L., Chan K., Lesslauer W., Lee J., Ying X.Y., and Ruddle N.H. Lymphocyte traffic in lymphoid organ neogenesis: differential roles of Ltalpha and LTalphabeta. Adv. Exp. Med. Biol. 512 (2002) 43-48
12. Fan L., Reilly C.R., Luo Y., Dorf M.E., and Lo D. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J. Immunol. 164 (2000) 3955-3959
13. Fava R.A., Notidis E., Hunt J., Szanya V., Ratcliffe N., Ngam-Ek A., De Fougerolles A.R., Sprague A., and Browning J.L. A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J. Immunol. 171 (2003) 115-126
14. Fu Y.X., and Chaplin D.D. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17 (1999) 399-433
15. Gagnerault M.C., Luan J.J., Lotton C., and Lepault F. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 196 (2002) 369-377
16. Gommerman J.L., and Browning J.L. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3 (2003) 642-655
17. Gommerman J.L., Giza K., Perper S., Sizing I., Ngam-Ek A., Nickerson-Nutter C., and Browning J.L. A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. J. Clin. Invest. 112 (2003) 755-767
18. Green E.A., and Flavell R.A. Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice. Immunol. Rev. 169 (1999) 11-22
19. Guerder S., Picarella D.E., Linsley P.S., and Flavell R.A. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91 (1994) 5138-5142
20. Hanninen A., Taylor C., Streeter P.R., Stark L.S., Sarte J.M., Shizuru J.A., Simell O., and Michie S.A. Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J. Clin. Invest. 92 (1993) 2509-2515
21. Hjelmstrom P., Fjell J., Nakagawa T., Sacca R., Cuff C.A., and Ruddle N.H. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 156 (2000) 1133-1138
22. Hoglund P., Mintern J., Waltzinger C., Heath W., Benoist C., and Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189 (1999) 331-339
23. Jaakkola I., Jalkanen S., and Hanninen A. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice. Eur. J. Immunol. 33 (2003) 3255-3264
24. Levisetti M.G., Suri A., Frederick K., and Unanue E.R. Absence of lymph nodes in NOD mice treated with lymphotoxin-beta receptor immunoglobulin protects from diabetes. Diabetes 53 (2004) 3115-3119
25. Lo J.C., Chin R.K., Lee Y., Kang H.S., Wang Y., Weinstock J.V., Banks T., Ware C.F., Franzoso G., and Fu Y.X. Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J. Clin. Invest. 112 (2003) 1495-1505
26. Ludewig B., Odermatt B., Landmann S., Hengartner H., and Zinkernagel R.M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 188 (1998) 1493-1501
27. Luther S.A., Lopez T., Bai W., Hanahan D., and Cyster J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12 (2000) 471-481
28. Luther S.A., Bidgol A., Hargreaves D.C., Schmidt A., Xu Y., Paniyadi J., Matloubian M., and Cyster J.G. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169 (2002) 424-433
29. Mackay F., and Browning J.L. Turning off follicular dendritic cells. Nature 395 (1998) 26-27
30. Mackay F., Majeau G.R., Lawton P., Hochman P.S., and Browning J.L. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27 (1997) 2033-2042
31. Mackay F., Browning J.L., Lawton P., Shah S.A., Comiskey M., Bhan A.K., Mizoguchi E., Terhorst C., and Simpson S.J. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 115 (1998) 1464-1475
32. Moyron-Quiroz J.E., Rangel-Moreno J., Kusser K., Hartson L., Sprague F., Goodrich S., Woodland D.L., Lund F.E., and Randall T.D. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10 (2004) 927-934
33. Ngo V.N., Korner H., Gunn M.D., Schmidt K.N., Riminton D.S., Cooper M.D., Browning J.L., Sedgwick J.D., and Cyster J.G. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189 (1999) 403-412
34. Picarella D.E., Kratz A., Li C.B., Ruddle N.H., and Flavell R.A. Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. USA 89 (1992) 10036-10040
35. Picarella D.E., Kratz A., Li C.B., Ruddle N.H., and Flavell R.A. Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J. Immunol. 150 (1993) 4136-4150
36. Ruddle N.H. Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development. Immunol. Res. 19 (1999) 119-125
37. Spiotto M.T., Yu P., Rowley D.A., Nishimura M.I., Meredith S.C., Gajewski T.F., Fu Y.X., and Schreiber H. Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 17 (2002) 737-747
38. Spiotto M.T., Rowley D.A., and Schreiber H. Bystander elimination of antigen loss variants in established tumors. Nat. Med. 10 (2004) 294-298
39. Tisch R., and McDevitt H. Insulin-dependent diabetes mellitus. Cell 85 (1996) 291-297
40. Wang J., Chun T., Lo J.C., Wu Q., Wang Y., Foster A., Roca K., Chen M., Tamada K., Chen L., et al. The critical role of LIGHT, a TNF family member, in T cell development. J. Immunol. 167 (2001) 5099-5105
41. Wang J., Foster A., Chin R., Yu P., Sun Y., Wang Y., Pfeffer K., and Fu Y.X. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function. Eur. J. Immunol. 32 (2002) 1969-1979
42. Ware C.F. Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol. 23 (2005) 787-819
43. Wu Q., Wang Y., Wang J., Hedgeman E.O., Browning J.L., and Fu Y.X. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J. Exp. Med. 190 (1999) 629-638
44. Wu Q., Salomon B., Chen M., Wang Y., Hoffman L.M., Bluestone J.A., and Fu Y.X. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J. Exp. Med. 193 (2001) 1327-1332
45. Yang X.D., Sytwu H.K., McDevitt H.O., and Michie S.A. Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice. Diabetes 46 (1997) 1542-1547